Switch to:
More From Other Websites
3 Top-Rated Biotechs Could Take Buy Points Soon Mar 31 2015
Why Citigroup Removed Gilead Sciences From Its 'Most Preferred' List Mar 30 2015
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 26 2015
One analyst is convinced the biotech stock plunge is 'misguided' Mar 26 2015
Two Healthcare Stocks Provide Antidotes To Wild Market Swings Mar 24 2015
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Mar 16 2015
Affymetrix Hits 52-Week High on Stellar Q4, Positive Outlook - Analyst Blog Mar 13 2015
Analyst: Alexion Pharmaceuticals Pipeline Is Undervalued Mar 11 2015
Biotech pros’ top 8 stock picks Mar 09 2015
New Data from First Natural History Study in Juveniles with Hypophosphatasia (HPP) Showing... Mar 07 2015
New Data from First Natural History Study in Juveniles with Hypophosphatasia (HPP) Showing... Mar 07 2015
FDA Grants Priority Review for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia Mar 02 2015
FDA Grants Priority Review for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia Mar 02 2015
Alexion Joins Patient Organizations Worldwide in Support of International Rare Disease Day 2015 Mar 01 2015
Alexion Receives CHMP Positive Opinions for Important Updates to the EU Label for Soliris®... Feb 27 2015
Alexion Joins Patient Organizations Worldwide in Support of International Rare Disease Day 2015 Feb 27 2015
Alexion to Present at Investor Conferences Feb 23 2015
Alexion to Present at Investor Conferences Feb 23 2015
ALEXION PHARMACEUTICALS INC Financials Feb 13 2015
New Data from a Natural History Study in Patients with Infantile- and Juvenile-Onset... Feb 09 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK